Therefore, HCP-LCE may be expected to cause milder side effects compared to EGFR high affinity binding antibodies such as cetuximab, for which the main side effect is skin toxicity, including rash, dry skin, hair growth disturbances and nail changes (39, 40). The gene discussed is EGFR; the disease is neoplasm.